CLINICAL TRIALS PROFILE FOR DOBUTREX
✉ Email this page to a colleague
All Clinical Trials for DOBUTREX
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00219388 ↗ | Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients. | Completed | Orion Corporation, Orion Pharma | Phase 4 | 2002-11-01 | The purpose of this study is to compare the effects of levosimendan with dobutamine on heart function in patients suffering of severe chronic heart failure. |
| NCT00763035 ↗ | Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) | Terminated | Astellas Pharma US, Inc. | Early Phase 1 | 2009-01-01 | The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an imaging agent with cardiac MR. If found useful, it will help us establish a protocol for regadenoson stress MR perfusion (Regadenoson stress test with cardiac MR).The investigators will compare regadenoson with dobutamine so each participant will undergo two studies. A cardiac MR stress test with regadenoson and with dobutamine. The investigators participants will include patients with history of COPD and Asthma, so it will also help us determine feasibility of Regadenoson in these patient's subgroups. |
| NCT00763035 ↗ | Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) | Terminated | Wake Forest Baptist Health | Early Phase 1 | 2009-01-01 | The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an imaging agent with cardiac MR. If found useful, it will help us establish a protocol for regadenoson stress MR perfusion (Regadenoson stress test with cardiac MR).The investigators will compare regadenoson with dobutamine so each participant will undergo two studies. A cardiac MR stress test with regadenoson and with dobutamine. The investigators participants will include patients with history of COPD and Asthma, so it will also help us determine feasibility of Regadenoson in these patient's subgroups. |
| NCT00763035 ↗ | Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) | Terminated | Wake Forest University Health Sciences | Early Phase 1 | 2009-01-01 | The goal of this research is to determine the utility of Regadenoson (Lexiscan)for use as an imaging agent with cardiac MR. If found useful, it will help us establish a protocol for regadenoson stress MR perfusion (Regadenoson stress test with cardiac MR).The investigators will compare regadenoson with dobutamine so each participant will undergo two studies. A cardiac MR stress test with regadenoson and with dobutamine. The investigators participants will include patients with history of COPD and Asthma, so it will also help us determine feasibility of Regadenoson in these patient's subgroups. |
| NCT01271153 ↗ | Effects of Dobutamine on Microcirculation, Regional and Peripheral Perfusion in Septic Shock Patients | Completed | Pontificia Universidad Catolica de Chile | N/A | 2010-08-01 | The investigators hypothesize that dobutamine is able to revert negative redistribution of flow by inducing a selective vasodilatory effect on hypoperfused territories, particularly at the sublingual and gastric mucosa, and at the peripheral tissues. The investigators designed a randomized, cross-over, placebo-controlled study looking at the acute physiologic effects of 5 mcg/kg/min fixed-dose of dobutamine on cardiac function, microcirculation, gastric mucosal, hepatosplanchnic, and peripheral perfusion in septic shock patients. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DOBUTREX
Condition Name
Clinical Trial Locations for DOBUTREX
Trials by Country
Clinical Trial Progress for DOBUTREX
Clinical Trial Phase
Clinical Trial Sponsors for DOBUTREX
Sponsor Name
